Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
暂无分享，去创建一个
Liying Zhang | P. Cheung | M. McGuffin | G. Morton | W. Chu | A. Loblaw | A. Ravi | C. Tseng | Stanley K. Liu | A. Mamedov | M. Davidson | J. Helou | Y. Alayed | R. Correa | H. Chung | A. Shahid